Actualités

Renault-Nissan-Mitsubishi

Alliance Ventures Invests in Tekion, the Next-Gen Digital Cloud Platform for Automotive Retail

Paris (ots/PRNewswire) - Investment in US provider of dealership software systems marks a new commitment for digital consumer experience in first year of corporate venture capital fund. Alliance Ventures, the strategic venture capital arm of Renault-Nissan-Mitsubishi, has announced today a new investment in digital technologies and services by investing in Tekion, a US ...

Nestlé S.A.

Nestlé Accelerates Action to Tackle Plastic Waste

Vevey, Switzerland (ots/PRNewswire) - Nestlé today laid out its broader vision to achieve a waste-free future and announced a series of specific actions towards meeting its April 2018 commitment (https://www.nestle.com/media/pressreleases/allpressreleases/nestle-recyclable-reusable-packaging-by-2025) to make 100% of its packaging recyclable or reusable by 2025, with a particular focus on avoiding plastic-waste. (Logo: ...

Parkopedia

Parkopedia's Parking Services Extended to Include C-Class, E-Class, S-Class

Detroit (ots/PRNewswire) - - Parkopedia to provide Mercedes Benz cars with parking data for both off and on-street parking; - The parking service has been extended to complete range of passenger cars, including C-Class, E-Class & S-Class vehicles; - Founded in 2007, Parkopedia now provides detailed information on over 60 million parking spaces and offers parking ...

immigon portfolioabbau ag

EANS-Adhoc: immigon portfolioabbau ag/immigon resolves to withdraw Perpetual Non Cumulative Participation Capital Certificates ISIN XS0359924643 from admission to trading (delisting) at Luxembourg Stock Exchange

issuer: immigon portfolioabbau ag Peregringasse 2 A-1090 Wien phone: +43 (0)1 313 40-0 FAX: mail: info@immigon.com WWW: www.immigon.com ISIN: AT000B056544, AT000B053442,XS0275528627,AT000B060462,AT000B115902, indexes: stockmarkets: Luxembourg Stock Exchange, Wien language: English ...

Wolford Aktiengesellschaft

EANS-Adhoc: Wolford AG: Adjustment of outlook

issuer: Wolford Aktiengesellschaft Wolfordstrasse 1 A-6900 Bregenz phone: +43(0) 5574 690-1268 FAX: +43(0) 5574 690-1219 mail: investor@wolford.com WWW: http://company.wolford.com ISIN: AT0000834007 indexes: ATX GP stockmarkets: Frankfurt, Wien, New York language: English ...

Schulthess Zimmermann & Jauch

3

Diversity and leadership: key factors in sustained business success

Super B

Super B: More Focus Needed to Enable Energy Transition

Hengelo, The Netherlands (ots/PRNewswire) - Split-off Lithium Werks and Koolen Industries offers new opportunities Battery and energy storage specialist Lithium Werks today announced to specialize in order to achieve their mission to enable the energy transition. The business continues in two group companies: Koolen Industries (http://www.koolenindustries.com) and Lithium Werks. The split will enable the company to ...

Firmenich

Firmenich Joins RE100 and Reaches 100% Renewable Power Across Its European and US Manufacturing Sites

Geneva (ots/PRNewswire) - Firmenich is proud to have joined RE100, a global initiative of the world's most influential companies, all committed to 100% renewable power. Today, Firmenich manufacturing sites in the U.S. and Europe are operating with 100% renewable electricity, as the Group gets closer to meeting its ...

Schweizerischer Nationalfonds / Fonds national suisse

Speeding up genetic diagnosis of Huntington's disease

Bern (ots) - Elongated segments of DNA cause Huntington's disease and certain other disorders of the brain. Researchers funded by the SNSF have developed a method to determine the length of the mutated genes quickly and easily. People with Huntington's disease suffer from jerky body movements and decreasing mental abilities. The condition usually leads to death 15-20 years after diagnosis. The cause of the disease is a ...

Atrium European Real Estate Limited

EANS-News: Atrium European Real Estate Limited / Notice of Full Year 2018 Results

issuer: Atrium European Real Estate Limited Seaton Place 11-15 UK-JE4 0QH St Helier Jersey / Channel Islands phone: +44 (0)20 7831 3113 FAX: mail: richard.sunderland@fticonsulting.com WWW: http://www.aere.com ISIN: JE00B3DCF752 indexes: stockmarkets: Luxembourg Stock Exchange, Wien language: English ...

AGRANA Beteiligungs-AG

EANS-News: AGRANA registers significant earnings reduction for first three quarters of 2018|19

issuer: AGRANA Beteiligungs-AG F.-W.-Raiffeisen-Platz 1 A-1020 Wien phone: +43-1-21137-0 FAX: +43-1-21137-12926 mail: info.ab@agrana.com WWW: www.agrana.com ISIN: AT000AGRANA3 indexes: WBI stockmarkets: Stuttgart, Wien, Frankfurt, Berlin language: English ...

Medasense Biometrics Ltd

Medasense Announces Compatibility with Philips IntelliVue Patient Monitors

Ramat Gan, Israel (ots/PRNewswire) - Medasense Biometrics Ltd., developer of the physiological pain-response monitoring technology (NOL® -- the Nociception Level Index), now supports Philips IntelliVue Patient Monitors for anesthesia and critical care monitoring. (Photo: https://mma.prnewswire.com/media/805789/Medasense_PMD_200_Monitor.jpg ) Commercially available in ...

AT & S Austria Technologie & Systemtechnik Aktiengesellschaft

EANS-Adhoc: AT & S Austria Technologie & Systemtechnik Aktiengesellschaft / AT&S confirms the EBITDA margin expected for the financial year 2018/19 and slightly adjusts revenue forecast

issuer: AT & S Austria Technologie & Systemtechnik Aktiengesellschaft Fabriksgasse 13 A-8700 Leoben phone: 03842 200-0 FAX: mail: ir@ats.net WWW: www.ats.net ISIN: AT0000969985 indexes: WBI, VÖNIX, ATX GP stockmarkets: Wien language: English ...

5GAA - 5G Automotive Association e.V.

5G Automotive Association at CES 2019: Highlighting connected mobility through 5G / The 5G Automotive Association and 47 of its members will be present at CES 2019

Las Vegas (ots) - The 5G Automotive Association (5GAA), the global, cross-industry organization of companies working together on future mobility solutions, will be at CES 2019 to discuss the future of transportation through 5G - including the critical role of Cellular Vehicle-to-Everything (C-V2X) deployment. The 5G ...

Debiopharm International SA

Debiopharm Group regains the commercial rights to Trelstar® (Triptorelin pamoate) and looks for new partners in North America

Lausanne, Switzerland (ots) - Debiopharm and Allergan agree to transition the rights to commercialize Trelstar to new licensees. Debiopharm is in advanced discussion with a potential partner in Canada and is engaged in a bidding process for US rights. Debiopharm Group(TM) (Debiopharm - www.debiopharm.com), a ...

Loylogic

Royal Jordanian and Loylogic Deepen their Partnership by Launching a Global Reward Portal as well as Buy and Gift Miles

Zurich, Switzerland/ Amman, Jordan (ots) - Loylogic, the global leader in e-commerce and e-payment solutions for loyalty programs, and Royal Jordanian Airlines have extended their partnership by launching an additional three of Loylogic's leading solutions for their Royal Club loyalty program: Buy and Gift Miles ...

Daiichi Sankyo Europe GmbH

Daiichi Sankyo Europe Enters into European Licensing Agreement with Esperion for Bempedoic Acid and the Bempedoic Acid / Ezetimibe Combination Tablet

Munich (ots/PRNewswire) - - Daiichi Sankyo Europe will market oral bempedoic acid and bempedoic acid / ezetimibe combination tablet in the European Economic Area and Switzerland - Bempedoic acid is a first-in-class, oral, once-daily ATP Citrate Lyase (ACL) inhibitor that reduces cholesterol and fatty acid synthesis ...

NEMIS TECHNOLOGIES AG

NEMIS Technologies Ltd. Successfully Closes First Seed Financing Round / Swiss Diagnostic Startup Closes Seed Financing Round of CHF 3 Million Within the First Year

Sophia Genetics

SOPHiA GENETICS Raises $77 Million to Accelerate the Democratization of Data-Driven Medicine

San Francisco (ots/PRNewswire) - SOPHiA GENETICS, a leading health tech company, announced today the closing of a $77 million investment round to accelerate the democratization of Data-Driven Medicine. The round was led by Generation Investment Management, a pioneer of sustainable investing, with offices in London and San Francisco. Generation were joined by Idinvest ...

ProBioGen AG

ProBioGen's GlymaxX® ADCC Enhancement Technology Used by Betta Pharmaceuticals

Berlin (ots/PRNewswire) - Bispecific Antibody for Cancer Treatment Optimized by GlymaxX® Technology ProBioGen AG, a premier service & technology provider for complex therapeutic antibodies and glycoproteins, announced today that the company achieved an undisclosed milestone payment from Merus N.V. (Nasdaq: MRUS) based on Merus' grant of an exclusive license to ...

NORGINE B.V. and KOREA PHARMA CO., LTD.

NORGINE B.V. and KOREA PHARMA CO., LTD. Enter Into Exclusive Licence Agreement for the Commercialisation of PLENVU® in the Republic of Korea

Amsterdam and Seoul, South Korea (ots/PRNewswire) - - Norgine to receive a significant upfront payment and undisclosed sums in sales milestones along with double-digit percentage royalties - Norgine retains full commercial rights to PLENVU® in all unlicensed countries NORGINE B.V. (Norgine), a leading European ...

DX.Exchange

DX.Exchange and Fingenom Group Announce Strategic Partnership

Tallinn, Estonia (ots/PRNewswire) - DX.Exchange engages AlgoZ, a Fingenom company, to provide market making and liquidity solutions on its platform DX.Exchange announced today that it has engaged AlgoZ, a Fingenom Group company, to provide market making services and additional liquidity solutions on its exchange. DX.Exchange has retained AlgoZ to provide liquidity services on all cryptocurrency pairs listed on the ...

Seal Network

New Anti-Counterfeiting Platform Secures Up To 99% of All Sorts of Fraud for Consumer Brands

Amsterdam (ots/PRNewswire) - - Dutch startup Seal introduces world's most secure anti-counterfeiting and digital twin platform to protect large consumer brands Seal is a new anti-counterfeiting platform that solves up to 99% of all types of product fraud. It protects consumers from fakes with a simple app that lets you scan to verify the authenticity of your favorite ...

Merck Healthcare Germany

Merck and Pfizer Provide Update on JAVELIN Ovarian 100 Trial of Avelumab in Previously Untreated Advanced Ovarian Cancer

Darmstadt, Germany and New York (ots/PRNewswire) - Not intended for US, Canada and UK-based media Merck and Pfizer Inc. (NYSE: PFE) today announced that data from a planned interim analysis of the Phase III JAVELIN Ovarian 100 study of avelumab* did not support the study's initial hypothesis, and therefore the ...